Invent Medic Sweden AB (XSAT:IMS) ROCE % : -115.07% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Invent Medic Sweden AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Invent Medic Sweden AB's annualized ROCE % for the quarter that ended in Mar. 2024 was -115.07%.

Invent Medic Sweden AB ROCE % Historical Data

The historical data trend for Invent Medic Sweden AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invent Medic Sweden AB ROCE % Chart

Invent Medic Sweden AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-117.58

-159.84

-115.06

-95.64

-118.15

Invent Medic Sweden AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-99.01	-79.75	-110.67	-109.43	-115.07

Invent Medic Sweden AB ROCE % Calculation

Invent Medic Sweden AB's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-8.15	/	( ( (9.361 - 3.31)	+	(10.346 - 2.601) )	/ 2 )
	=	-8.15	/	( (6.051	+	7.745)	/ 2 )
	=	-8.15	/	6.898
	=	-118.15 %

Invent Medic Sweden AB's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-7.104	/	( ( (10.346 - 2.601)	+	(10.589 - 5.987) )	/ 2 )
	=	-7.104	/	( ( 7.745	+	4.602 )	/ 2 )
	=	-7.104	/	6.1735
	=	-115.07 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Invent Medic Sweden AB (XSAT:IMS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Invent Medic Sweden AB ROCE % Related Terms

Thank you for viewing the detailed overview of Invent Medic Sweden AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Invent Medic Sweden AB (XSAT:IMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Invent Medic Sweden AB (XSAT:IMS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Medicon Village, Scheele path 2, Lund, SWE, 223 81

Website

http://www.inventmedic.com

Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.

Invent Medic Sweden AB (XSAT:IMS) Headlines

From GuruFocus

5 Companies Reach 52-Week Highs

By yifan900 yifan900 • 02-13-2018

Well-Known Companies Reach 52 Week Highs

By yifan900 yifan900 • 10-11-2016

The Big 3: Larry Robbins' Top 2nd-Quarter Buys

By James Li James Li • 08-16-2016

Weekly Insider Sells Highlight: IMS, NOW, BMY, EA

By James Xiao James Xiao • 08-11-2015

Healthcare Informatics: A Value Investor's Perspective

By Thomas Macpherson Thomas Macpherson • 10-23-2015